Home
Into Bettermore Consulting
Bettermore News
Xiaomo future
Only you
网站设置
中文
中文
Home
Into Bettermore Consulting
Bettermore News
Bettermore Forum
Industry News
Clock in Bettermore
Xiaomo future
Growth Path
Personnel Training
Growth story
Only you
Internal recruitment
Contact us
Bettermore News
Bettermore Forum
Industry News
Clock in Bettermore
Industry News
默沙东、BMS、罗氏、AZ华山论剑,TIGIT绝地反击,石药、君实加码FIC!2023 ASCO哪些值得看?
Time:2023-06-13
国产ADC的创新空间:DS-8201不是高山,而是灯塔
Time:2023-06-05
ASCO爆热!DS-8201最新数据披露,恒瑞、科伦、百济、和誉,本土FIC、BIC狂奔,谁的含金量更高?
Time:2023-05-30
最新!首个治疗阿尔兹海默激越药物Rexult获批上市
Time:2023-05-15
信达 PD-1 获批 NSCLC 领域独家适应症,大冢制药/灵北制药首款阿尔茨海默症激越药获批上市
Time:2023-05-15
百济神州 BTK 一季度全球销售突破 14 亿元,海外收入大涨超一倍
Time:2023-05-08
BIC疯狂,FIC崭露头角,热门靶点占半壁江山,中国2023潜力20亿新药都有谁?
Time:2023-04-24
神经病学竞技场,看顶级药企如何PK?
Time:2023-04-19
诺和诺德、礼来「领卷」GLP-1 赛道!信达、正大天晴、华东医药…国内市场硝烟四起
Time:2023-04-17
君实「特瑞普利单抗」第 7 项适应症报上市;恒瑞 ADC 新药启动新 III 期临床
Time:2023-04-17
Home
Prev
1
2
3
4
Next
End
网站备案号:
沪ICP备19030974号-1
|© Bettermore. All rights reserved.